DHR vs GILD
Danaher Corporation vs Gilead Sciences — AI-powered side-by-side comparison
DHR
Danaher Corporation
63
Buy
VS
GILD
Gilead Sciences
64
Buy
| Metric | DHR | GILD |
|---|
| AI Score |
63
|
64
|
| Price |
$209.32
|
$133.10
|
| P/E Ratio |
36.24×
|
-51.23×
|
| ROE |
6.9%
|
37.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
58.5%
|
79.6%
|
| Debt / Equity |
0.51×
|
0.21×
|
| Dividend Yield |
0.7%
|
2.4%
|
| RSI (14) |
67.2
|
54.4
|
| Beta |
0.796
|
0.336
|
| Expected Upside |
+1.6%
|
+18.2%
|
AI Committee View
Current Innellis committee reasoning for DHR versus GILD.
GILD leads by 1 points.
GILD scores 64/100 (Buy) versus DHR at 63/100 (Buy).
DHR Committee View
80% agreement
5 analysts
The primary driver is news sentiment is positive (+0.40 across 26 articles, 14d). The main limiting factor is p/e of 36.2 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 36.2 is moderate-to-rich — Value
GILD Committee View
50% agreement
4 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical